Structures by: Arkhipov S. G.
Total: 33
Disodium 2-amino-6-oxo-6,7-dihydro-1H-purine-1,7-diide heptahydrate
2(Na),7(H2O),C5H3N5O
CrystEngComm (2019) 21, 30 4484
a=10.5670(3)Å b=11.7875(3)Å c=11.2791(3)Å
α=90° β=101.443(3)° γ=90°
Disodium 2-amino-6-oxo-6,7-dihydro-1H-purine-1,7-diide heptahydrate
2(Na),7(H2O),C5H3N5O
CrystEngComm (2019) 21, 30 4484
a=10.5372(6)Å b=11.191(6)Å c=10.8339(7)Å
α=90° β=102.017(6)° γ=90°
Disodium 2-amino-6-oxo-6,7-dihydro-1H-purine-1,7-diide heptahydrate
2(Na),7(H2O),C5H3N5O
CrystEngComm (2019) 21, 30 4484
a=10.5575(8)Å b=11.580(7)Å c=11.1164(8)Å
α=90° β=101.657(7)° γ=90°
Disodium 2-amino-6-oxo-6,7-dihydro-1H-purine-1,7-diide heptahydrate
2(Na),7(H2O),C5H3N5O
CrystEngComm (2019) 21, 30 4484
a=10.5398(6)Å b=11.142(5)Å c=10.8026(6)Å
α=90° β=102.027(5)° γ=90°
Disodium 2-amino-6-oxo-6,7-dihydro-1H-purine-1,7-diide heptahydrate
2(Na),7(H2O),C5H3N5O
CrystEngComm (2019) 21, 30 4484
a=10.5403(10)Å b=11.077(10)Å c=10.7701(10)Å
α=90° β=101.972(8)° γ=90°
Disodium 2-amino-6-oxo-6,7-dihydro-1H-purine-1,7-diide heptahydrate
2(Na),7(H2O),C5H3N5O
CrystEngComm (2019) 21, 30 4484
a=10.5380(7)Å b=11.433(7)Å c=10.9920(8)Å
α=90° β=101.824(6)° γ=90°
Disodium 2-amino-6-oxo-6,7-dihydro-1H-purine-1,7-diide heptahydrate
2(Na),7(H2O),C5H3N5O
CrystEngComm (2019) 21, 30 4484
a=10.5441(7)Å b=11.239(7)Å c=10.8819(8)Å
α=90° β=101.974(6)° γ=90°
Tenoxicam acetone solvate
C13H11N3O4S2,C3H6O
CrystEngComm (2019) 21, 36 5392
a=8.9341(4)Å b=8.9659(5)Å c=11.9315(6)Å
α=75.325(4)° β=81.348(4)° γ=89.620(4)°
Tenoxicam chloroform II solvate
C13H11N3O4S2,2(CHCl3)
CrystEngComm (2019) 21, 36 5392
a=9.5960(19)Å b=16.740(3)Å c=28.301(6)Å
α=90° β=90° γ=90°
Tenoxicam acetonitrile solvat
C13H11N3O4S2,C2H3N
CrystEngComm (2019) 21, 36 5392
a=9.1718(3)Å b=8.9965(3)Å c=21.1092(8)Å
α=90° β=98.591(4)° γ=90°
Tenoxicam dimethylformamide solvate
C13H11N3O4S2,C3H7NO
CrystEngComm (2019) 21, 36 5392
a=9.1060(4)Å b=9.4381(4)Å c=11.6586(6)Å
α=74.530(4)° β=77.500(4)° γ=85.545(3)°
Tenoxicam chloroform III solvate
C13H11N3O4S2,CHCl3
CrystEngComm (2019) 21, 36 5392
a=13.579(3)Å b=10.135(2)Å c=14.880(3)Å
α=90° β=116.58(3)° γ=90°
Tenoxicam chloroform I solvate
2(C13H11N3O4S2),2(CHCl3)
CrystEngComm (2019) 21, 36 5392
a=10.6019(12)Å b=12.7810(10)Å c=28.841(2)Å
α=90° β=92.076(10)° γ=90°
Metacetamol hemihydrate
2(C8H9NO2),H2O
Acta Crystallographica Section C (2019) 75, 11
a=12.7626(4)Å b=6.92827(14)Å c=19.7011(4)Å
α=90° β=104.619(3)° γ=90°
L-ascorbic acid picolinic acid cocrystal
C6H8O6,C6H5NO2
Acta Crystallographica Section B (2020) 76, 6
a=29.1612(4)Å b=9.20700(10)Å c=4.73870(10)Å
α=90° β=90° γ=90°
L-ascorbic acid picolinic acid cocrystal
C6H8O6,C6H5NO2
Acta Crystallographica Section B (2020) 76, 6
a=29.0583(2)Å b=9.15479(8)Å c=4.70223(4)Å
α=90° β=90° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.2256(7)Å b=5.67647(16)Å c=32.0621(7)Å
α=90° β=100.170(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.2633(8)Å b=5.67322(19)Å c=32.0530(8)Å
α=90° β=100.076(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.3300(7)Å b=5.67423(16)Å c=32.0776(7)Å
α=90° β=99.937(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.3889(8)Å b=5.67352(19)Å c=32.0754(8)Å
α=90° β=99.818(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.4563(9)Å b=5.67251(19)Å c=32.0779(8)Å
α=90° β=99.653(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.5229(9)Å b=5.6692(2)Å c=32.0754(9)Å
α=90° β=99.486(4)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.6021(9)Å b=5.6701(2)Å c=32.0856(9)Å
α=90° β=99.299(4)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.6777(9)Å b=5.66500(18)Å c=32.0878(8)Å
α=90° β=99.115(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.7528(11)Å b=5.6663(2)Å c=32.0956(10)Å
α=90° β=98.955(4)° γ=90°
4-Carboxyanilinium pyrazine-2-carboxylate
C7H8NO2,C5H3N2O2
Acta Crystallographica Section E (2018) 74, 12 1923-1927
a=5.95233(16)Å b=3.80345(11)Å c=25.6879(7)Å
α=90° β=95.037(2)° γ=90°
4-Carboxyanilinium pyrazine-2-carboxylate
C7H8NO2,C5H3N2O2
Acta Crystallographica Section E (2018) 74, 12 1923-1927
a=5.95842(16)Å b=3.73769(10)Å c=25.5943(6)Å
α=90° β=95.362(2)° γ=90°
Meloxicam acetylenedicarboxylic acid
2C14H13N3O4S2,C4H2O4
Acta Crystallographica Section E (2016) 72, 12 1856-1859
a=7.3861(3)Å b=8.5629(3)Å c=15.1619(6)Å
α=75.839(3)° β=79.196(3)° γ=70.100(3)°
<i>DL</i>-Serinium semi-maleate
C3H8NO3,C4H3O4
Acta Crystallographica Section C (2013) 69, 5 517-521
a=5.9406(3)Å b=8.9527(4)Å c=9.3796(3)Å
α=79.239(3)° β=75.528(3)° γ=86.771(4)°
<i>L</i>-Lisinium hydrogen maleate hemihydrate
C6H14NO2,C4H3O4,0.5(H2O)
Acta Crystallographica Section C (2015) 71, 7
a=11.5217(9)Å b=5.9974(3)Å c=19.3426(12)Å
α=90° β=95.848(6)° γ=90°
<i>L</i>-Norvalinium hydrogen maleate--<i>L</i>-norvaline (1/1)
C5H11NO2,C4H3O4,C5H12NO2
Acta Crystallographica Section C (2015) 71, 7
a=12.2269(6)Å b=5.30779(17)Å c=15.4678(6)Å
α=90° β=113.055(5)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section C (2015) 71, 7
a=21.7231(19)Å b=5.6603(4)Å c=32.075(3)Å
α=90° β=98.950(8)° γ=90°
<i>L</i>-Serinium semi-maleate
C3H8NO3,C4H3O4
Acta Crystallographica Section C (2013) 69, 5 517-521
a=6.9527(11)Å b=6.5631(10)Å c=10.4284(19)Å
α=90.00° β=97.094(14)° γ=90.00°